CClinicalTrials.gg
CompletedNCT05433662Pan-ACTUpdated Jul 22, 2026Results posted

Pandemic Acceptance and Commitment Therapy (Pan-ACT): Telehealth Delivery With Older Veterans

An observational study in Psychological Stress, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-07-22.

Sponsored by VA Office of Research and Development · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
24
Ages
60 Years and older
Sex
All
01

Study summary

Older adults have been disproportionately impacted and distressed by the novel coronavirus (COVID-19) pandemic. Social distancing and stay-at-home orders have increased older adults' risk of social isolation and loneliness that will has led to a pandemic-induced fear of being in close proximity to other people. These fears and avoidant behaviors will have lasting effects if not treated with effective, safe, and convenient psychological interventions. This study will evaluate the acceptability and feasibility of delivering a small group intervention, called Acceptance and Commitment Therapy (ACT), through a telehealth modality to Veterans ages 60 and older who are experiencing pandemic-related emotional and physical distress. ACT helps decrease emotional suffering, improve well-being and promote positive behavior change by increasing one's psychological flexibility through the practice of mindfulness, acceptance, and values-based behaviors. The knowledge gained from this study will be used to better tailor the invention to meet the needs of older Veterans in an era of post-pandemic recovery.

Read the detailed description

Significance: Accounting for over 80% of COVID-19 related deaths in the United States, adults ages 60 and older have been disproportionately impacted by this pandemic more than any other age group. As a result, they may bear a heavy psychological burden in the months and years to come. Older adults have been labeled "vulnerable" to COVID-19 and strongly encouraged to adhere to "social distancing." This prevention measure is meant to mitigate the spread of the virus but has increased older adults' risk of social isolation and loneliness, which are two known correlates of increased morbidity and mortality in late life. Pandemic-related restrictions have decreased older adults' life-space mobility and negatively affected their physical and nutritional well-being, impairing their quality of life and potentially increasing their vulnerability to poorer outcomes if exposed to COVID-19. Research has documented a plethora of pandemic-related stressors that are common among older adults (e.g., fear of infection, loss of loved ones, financial repercussions) and the culminating psychological impact. Telehealth-adapted evidence-based psychological interventions are needed to address the psychosocial and physical toll of the pandemic among older Veterans. Acceptance and Commitment Therapy (ACT) decreases emotional suffering, improves well-being, promotes and supports healthy behavior changes, and treats a wide range of diagnoses by increasing psychological flexibility through mindfulness, acceptance, and values-based behaviors. Higher psychological flexibility has been associated with pandemic-related coping and well-being. Randomized studies of ACT with older adults are few but promising, and most research studies with this population have used a group format. While research on telehealth delivery of ACT for older adults is limited, preliminary results indicate it is feasible and as effective as ACT delivered in person.

Specific Aim: The proposed study will pilot a 10-session telehealth Pandemic ACT group intervention (i.e., Pan-ACT group) with Veterans ages 60 and older who are experiencing pandemic-related emotional and physical distress.

Methods and Procedures: Twenty-five older Veterans will be enrolled in this single-arm feasibility pilot trial. The intervention will be delivered weekly in 90-minute sessions of groups of four to five Veterans. Feasibility and acceptability of study procedures will be measured by referred-to-enrolled rate, telehealth access and capability, electronic data collection of outcome measures, and qualitative feedback on data collection procedures and measures. Feasibility and acceptability of the intervention will be measured by attendance; attrition; homework completion; participant ratings of the intervention's feasibility, acceptability, and fit; qualitative feedback; and treatment fidelity. Preliminary responsiveness of outcomes measures will be explored. Participants will complete measures of pandemic-related emotional and physical distress, psychological flexibility, depression, anxiety, social connectedness, perceived health, functional impairment, and meaningful engagement at baseline, posttreatment, and one-month follow-up. A brief midpoint assessment at week 5 of the group will consist of measures of social connectedness and functional impairment. Qualitative data will be gathered on perceived efficacy to implement intervention skills and specific emotional or behavioral changes participants have noticed in themselves as a result of the intervention.

Conclusion: The telehealth Pan-ACT Group is a mental and behavioral health rehabilitation intervention that focuses on helping older Veterans develop or recover coping skills that were lost or are no longer effective during the ongoing COVID-19 pandemic. The proposed study address a major research and clinical gap by gathering new knowledge for an urgent need, which will inform the development of a full-scale randomized controlled trial to evaluate the intervention's effectiveness.

02

Conditions studied

  • Psychological Stress

Browse trials for

Keywords

  • Older adult
  • acceptance and commitment therapy
  • telehealth
  • pandemic
03

In context

Stress, Psychological

783 studies on the registry are indexed under Stress, Psychological; 128 are open to participants now.

This study's enrollment of 24 is below the median of 174 across 139 observational studies indexed under Stress, Psychological.

Browse Stress, Psychological studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.

Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Veterans ages 60 and older receiving services at the Tuscaloosa VA Medical Center (TVAMC) were recruited from primary care, home-based primary care, and mental health clinics.

Inclusion criteria

  • Veteran
  • receives care at Tuscaloosa VA Medical Center
  • score of 9 or greater on the COVID-19 Mental Health Impacts Scale
  • English speaking
  • provides written informed consent
  • age 60 or older

Exclusion criteria

Exclusion Criteria:

  • diagnosis of dementia
  • score of 31 or less on the Modified Telephone Interview for Cognitive Status
  • actively suicidal or homicidal
  • actively psychotic
  • unstable medical condition
  • active substance use disorder
  • currently participating in another cognitive behavioral therapy (CBT) intervention
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
24 participants (actual)
Patient registry
No

Groups and cohorts

  • Pandemic Acceptance and Commitment Therapy (Pan-ACT)

    Open label assignment to Pan-ACT group telehealth intervention.

    Behavioral: Pandemic Acceptance and Commitment Therapy (Pan-ACT)

Interventions

  • BehavioralPandemic Acceptance and Commitment Therapy (Pan-ACT)

    Pan-ACT is a 10-session, closed group, transdiagnostic intervention for older adults delivered by telehealth platform.

    Also known as: Acceptance and Commitment Therapy (ACT); ACT for Older Adults; The Third ACT

06

What researchers measure

Primary outcomes

  1. Acceptability of Study Protocol - Retention

    Retention is defined as number of participants who completed the post-treatment endpoint assessment (numerator) divided by the number of participants who signed informed consent (enrolled; denominator).

    Time frame: 14 weeks

  2. Feasibility of Study Protocol - Telehealth Capability

    Percent of participants enrolled (i.e., signed consent) who have telehealth capability for duration of intervention.

    Time frame: 14 weeks

  3. Acceptability of Intervention - Group Attendance

    Percent of participants who started the Pan-ACT intervention (denominator) and attended 70% or more of intervention sessions (numerator)

    Time frame: 14 weeks

Other outcomes

  1. Acceptability of Study Protocol - Enrollment

    The percent of individuals who were referred and pre-screened for the study (denominator) and subsequently enrolled (singed consent) in the study.

    Time frame: 14 weeks

  2. Acceptability of Study Protocol - Assessment Completion

    The percent of participants who began the Pan-ACT intervention (denominator) and subsequently completed all study assessments (numerator).

    Time frame: 14 weeks

  3. Feasibility of Study Protocol - Timeline

    Number of Pan-ACT intervention group cohorts that started as scheduled on timeline (numerator) divided by the total number of Pan-ACT intervention group cohorts.

    Time frame: Through study completion (approximately 2 years) last session at year 2 reported.

  4. Feasibility of Intervention - Treatment Fidelity

    The Acceptance and Commitment Therapy Fidelity Measure (ACT-FM) is a 25-item scale used by an independent fidelity reviewer to score the four domains of the Pan-ACT intervention that were delivered by the therapist during the Pan-ACT group sessions. Each item is rated on a 4-point Likert scale ranging from 0 ("this behavior never occurred") to 3 ("therapist consistently enacts this behavior"). The total ACT consistency score and total ACT inconsistency score were calculated by adding the scores for the four domains. ACT-FM score can range from 0 to 36. Higher scores indicate greater fidelity to the Pan-ACT intervention model. The study's target was to reach at least 26 points on average for the fidelity reviews.

    Time frame: Through study completion (approximately 2 years) last session at year 2 reported.

07

Results

Posted Jul 22, 2026
Limitations and caveats
The study enrollment was negatively impacted by the timing of the study launch, i.e. study recruitment started in 2022 after the COVID-19 pandemic social restrictions had been lifted and pandemic-related fears had been reduced once a COVID-19 vaccine was universally available. This resulted in a small sample size which is a limitation of the trial. Homework adherence could not be collected, so is no longer included as an outcome of the study.

Participant flow

Participants were recruited from the Tuscaloosa VA Medical Center located in Tuscaloosa, Alabama (AL). Participants were enrolled between December 20, 2022, and May 22, 2024.

Participant flow — Overall Study
MilestonePandemic Acceptance and Commitment Therapy (Pan-ACT)
Started24
Began pan-act group15
Completed15
Not completed9
Withdrew: Withdrawal by subject8
Withdrew: Lost to follow-up1

Outcome measures

PrimaryAcceptability of Study Protocol - Retention

Retention is defined as number of participants who completed the post-treatment endpoint assessment (numerator) divided by the number of participants who signed informed consent (enrolled; denominator).

Time frame:
14 weeks
Reported as:
Count of participants · Participants
Acceptability of Study Protocol - Retention
ParticipantsPandemic Acceptance and Commitment Therapy (Pan-ACT)
Acceptability of Study Protocol - Retention15
PrimaryFeasibility of Study Protocol - Telehealth Capability

Percent of participants enrolled (i.e., signed consent) who have telehealth capability for duration of intervention.

Time frame:
14 weeks
Reported as:
Count of participants · Participants
Feasibility of Study Protocol - Telehealth Capability
ParticipantsPandemic Acceptance and Commitment Therapy (Pan-ACT)
Feasibility of Study Protocol - Telehealth Capability12
PrimaryAcceptability of Intervention - Group Attendance

Percent of participants who started the Pan-ACT intervention (denominator) and attended 70% or more of intervention sessions (numerator)

Time frame:
14 weeks
Reported as:
Count of participants · Participants
Acceptability of Intervention - Group Attendance
ParticipantsPandemic Acceptance and Commitment Therapy (Pan-ACT)
Acceptability of Intervention - Group Attendance10
Other pre-specifiedAcceptability of Study Protocol - Enrollment

The percent of individuals who were referred and pre-screened for the study (denominator) and subsequently enrolled (singed consent) in the study.

Time frame:
14 weeks
Reported as:
Count of participants · Participants
Acceptability of Study Protocol - Enrollment
ParticipantsPandemic Acceptance and Commitment Therapy (Pan-ACT)
Acceptability of Study Protocol - Enrollment24
Other pre-specifiedAcceptability of Study Protocol - Assessment Completion

The percent of participants who began the Pan-ACT intervention (denominator) and subsequently completed all study assessments (numerator).

Time frame:
14 weeks
Reported as:
Count of participants · Participants
Acceptability of Study Protocol - Assessment Completion
ParticipantsPandemic Acceptance and Commitment Therapy (Pan-ACT)
Acceptability of Study Protocol - Assessment Completion13
Other pre-specifiedFeasibility of Study Protocol - Timeline

Number of Pan-ACT intervention group cohorts that started as scheduled on timeline (numerator) divided by the total number of Pan-ACT intervention group cohorts.

Time frame:
Through study completion (approximately 2 years) last session at year 2 reported.
Reported as:
Count of units · Group Cohorts
Feasibility of Study Protocol - Timeline
Group CohortsPandemic Acceptance and Commitment Therapy (Pan-ACT)
Feasibility of Study Protocol - Timeline3
Other pre-specifiedFeasibility of Intervention - Treatment Fidelity

The Acceptance and Commitment Therapy Fidelity Measure (ACT-FM) is a 25-item scale used by an independent fidelity reviewer to score the four domains of the Pan-ACT intervention that were delivered by the therapist during the Pan-ACT group sessions. Each item is rated on a 4-point Likert scale ranging from 0 ("this behavior never occurred") to 3 ("therapist consistently enacts this behavior"). The total ACT consistency score and total ACT inconsistency score were calculated by adding the scores for the four domains. ACT-FM score can range from 0 to 36. Higher scores indicate greater fidelity to the Pan-ACT intervention model. The study's target was to reach at least 26 points on average for the fidelity reviews.

Time frame:
Through study completion (approximately 2 years) last session at year 2 reported.
Reported as:
Mean · score on a scale
Feasibility of Intervention - Treatment Fidelity
score on a scalePandemic Acceptance and Commitment Therapy (Pan-ACT)
Feasibility of Intervention - Treatment Fidelity34.7 ± 1.8

Adverse events

Collected over Adverse Events were collected on participants who attended at least one Pan-ACT group (n=15) during their time in the study lasting up to 14 weeks. Adverse event data were collected over the 2-year study timeframe.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Pandemic Acceptance and Commitment Therapy (Pan-ACT)0/15 (0%)0/15 (0%)0/15 (0%)

Baseline characteristics

Signed Informed Consent

Age, Continuous
Age, Continuous(years)Pandemic Acceptance and Commitment Therapy (Pan-ACT)
Mean67.29 ± 3.56
Sex: Female, Male
Sex: Female, Male(Participants)Pandemic Acceptance and Commitment Therapy (Pan-ACT)
Female2
Male22
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Pandemic Acceptance and Commitment Therapy (Pan-ACT)
Black17
White7
Region of Enrollment
Region of Enrollment(Participants)Pandemic Acceptance and Commitment Therapy (Pan-ACT)
United States24
COVID-19 Mental Health Impacts Scale
COVID-19 Mental Health Impacts Scale(units on a scale)Pandemic Acceptance and Commitment Therapy (Pan-ACT)
Mean11.8 ± 3.76
08

Study locations

1 site
  • Tuscaloosa VA Medical Center, Tuscaloosa, AL
    Tuscaloosa, Alabama 35404-5015, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 9, 2024
  • Informed consent form · Feb 27, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05433662
Lead sponsor
VA Office of Research and Development
Collaborators
University of Alabama, Tuscaloosa
Responsible party
Sponsor
First posted
Jun 27, 2022
Start date
Dec 20, 2022
Primary completion
Dec 31, 2024
Completion
Jan 23, 2025
Results posted
Jul 22, 2026
Last update
Jul 22, 2026

Study contacts

Lori L Davis, MD
principal investigator · Tuscaloosa VA Medical Center, Tuscaloosa, AL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion